Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins

Antioxidants and Redox Signaling

Volumn 20, Issue 13, 2014, Pages 1977-1993

  Eble, Johannes A ^a,b   De Rezende, Flávia Figueiredo ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; INTEGRIN; REACTIVE OXYGEN METABOLITE;

CELL CONTACT; CONFORMATIONAL TRANSITION; CROSS LINKING; EXTRACELLULAR MATRIX; HUMAN; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; WOUND HEALING; ANIMAL; CELL ADHESION; CELLS; CYTOLOGY; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; CELL ADHESION; CELLS; EXTRACELLULAR MATRIX; HUMANS; INTEGRINS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84898478868     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5294     Document Type: Review

References (189)

1. Afratis N, Giateli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, Pavao MS, Tzanakakis GN, and Karamanos NK. Glycosaminoglycans: Key players in cancer cell biology and treatment. FEBS J 279: 1177-1197, 2012
2. Arnaout MA, Mahalingam B, and Xiong J-P. Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol 21: 381-410, 2005
3. Baldock C, Sheratt MJ, Shuttleworth CA, and Kielty CM. The supramolecular organization of collagen VI microfibrils. J Mol Biol 330: 297-307, 2003
4. Ball C, Vijayan KV, Nguyen T, Anthon K, Bray PF, Essex DW, and Dong JF. Glutathione regulates integrin aIIbb3-mediated cell adhesion under flow. Thromb Haemost 100: 857-863, 2008
5. Barczyk M, Carracedo S, and Gullberg D. Integrins. Cell Tissue Res 339: 269-280, 2009
6. Barnes JL and Gorin Y. Myofibroblast differentiation during fibrosis: Role of NAD(P)H oxidases. Kidney Int 79: 944-956, 2011
7. Beglova N, Blacklow SC, Takagi J, and Springer TA. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol 9: 282-287, 2002
8. Berg JT, Breen EC, Fu Z, Mathieu-Costello O, and West JB. Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma. Am J Respir Crit Care Med 158: 1921-1928, 1998
9. Bergmeier W and Hynes RO. Extracellular matrix proteins in hemostasis and thrombosis. Cold Spring Harb Perspect Biol 4: A005132, 2012
10. Block K, Eid A, Griendling KK, Lee D-Y, Wittrant Y, and Gorin Y. Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: Role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem 283: 24061-24076, 2008
11. Blue R, Li J, Steinberger J, Murcia M, Filizla M, and Coller BS. Effects of limiting extension at the aIIb genu on ligand binding to integrin aIIbb3. J Biol Chem285: 16604-17613, 2010
12. Bondi CD, Manickam N, Lee D-Y, Block K, Gorin Y, Abboud HE, and Barnes JL. NAD(P)H oxidase mediates TGFb1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21: 93-102, 2010
13. Bruckner P. Suprastructures of extracellular matrices: Paradigms of functions controlled by aggregates rather than molecules. Cell Tissue Res 339: 7-18, 2010
14. Butta N, Arias-Salgado EG, González-Manchón C, Ferrer M, Larrucea S, Ayuso MS, and Parrilla R. Disruptions of the b3 663-687 disulfide bridge confers constitutive activity to b3 integrins. Blood 102: 2491-2497, 2003
15. Calvete JJ, Henschen A, and Gonzalez-Rodriguez J. Complete localization of the intrachain disulfide bonds and the N-glycosylation points in the alpha-subunit of human platelet glycoprotein IIb. Biochem J 274: 63-71, 1989
16. Calvete JJ, Marcinkiewicz C, Monleón D, Esteve V, Celda B, Juárez P, and Sanz L. Snake venom disintegrins: Evolution of structure and function. Toxicon 45: 1063-1074, 2005
17. Carnesecchi S, Deffert C, Donati Y, Basset O, Hinz B, Preynat-Seauve O, Guichard C, Arbiser JL, Banfi B, Pache J-C, Barazzone-Argiroffo C, and Krause K-H. A key role of NOX4 in epithelial cell death during development of lung fibrosis. Antioxid Redox Signal 15: 607-619, 2011
18. Charles RL, Schröder E, May G, Free P, Gaffney PRJ, Wait R, Begum S, Heads RJ, and Eaton P. Protein sulfenation as a redox sensor; proteomics studies using a novel biotinylated dimedone analogue. Mol Cell Proteomics 6: 1473-1484, 2007
19. Chen P, Melchior C, Brons NHC, Schlegel N, Caen J, and Kieffer N. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human b3 integrins following disulfide bond disruption by cysteine mutations. J Biol Chem 276: 38628-38635, 2001
20. Chen VM and Hogg PJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost 4: 2533-2541, 2006
21. Chuang K-P, Tsai W-S, Wang Y-J, and Shieh C-C. Superoxide activates very late antigen-4 on an eosinophil cell line and increases cellular binding to vascular cell adhesion molecule-1. Eur J Immunol 33: 645-655, 2003
22. Corps EM, Robertson A, Dauncey MJ, and Kilshaw PJ. Role of the aI domain in ligand binding of integrin aEb7. Eur J Immunol 33: 2599-2608, 2003
23. Courtneidge SA. Cell migration and invasion in human disease: The Tks adaptor proteins. Biochem Soc Trans 40: 129-132, 2012
24. Cox D, Brennon M, and Moran N. Integrins as therapeutic targets: Lessons and opportunities. Nat Rev Drug Discov 9: 804-820, 2010
25. Curley GP, Blum H, and Humphries MJ. Integrin antagonists. Cell Mol Life Sci 56: 427-441, 1999
26. Dasgupta J, Kar S, Liu R, Joseph J, Kalyanaraman B, Remington SJ, Chen C, and Melendez JA. Reactive oxygen species control senescence-Associated matrix metalloproteinase-1 through c-Jun-N-Terminal kinase. J Cell Phys 225: 52-62, 2010
27. Denko NC, Fontana L, A., Hudson KM, Sutphin PD, Raychaudhuri S, Altman R, and Giaccia AJ. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22: 5907-5914, 2003
28. de Oliveira-Junior EB, Bustamente J, Newburger PE, and Condino-Neto A. The human NADPH oxidase: Primary and secondary defects impairing the respiratory burst function and the microbial ability of phagocytes. Scand J Immunol 73: 420-427, 2011
29. de Rezende FF, Martins Lima A, Niland S, Wittig I, Heide H, Schröder K, and Eble JA. Integrin a7b1 is a redoxregulated target of hydrogen peroxide in vascular smooth muscle cell adhesion Free Radic Biol Med 53: 521-531, 2012
30. Diaz B and Courtneidge SA. Redox signaling at invasive microdomains in cancer cells. Free Radic Biol Med 52: 247-256, 2012
31. Diaz B, Shani G, Pass I, Anderson D, Quintavalle M, and Courtneidge SA. Tks5-dependent, Nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal 2: Ra53, 2009
32. Durmowicz AG, Parks WC, Hyde DM, Mecham RP, and Stenmark KR. Persistence, re-expression, and induction of pulmonary arterial fibronectin, tropoelastin, and type I procollagen mRNA expression in neonatal hypoxic pulmonary hypertension. Am J Pathol 145: 1411-1420, 1994
33. Eble JA. Collagen-binding integrins as pharmaceutical targets. Curr Pharm Des 11: 867-880, 2005
34. Eble JA, Golbik R, Mann K, and Kü hn K. The a1b1 integrin recognition site of the basement membrane collagen molecule [a1(IV)]2a2(IV). EMBO J 12: 4795-4802, 1993
35. Eble JA, Kassner A, Niland S, Mö rgelin M, Grifka J, and Grä ssel S. Collagen XVI harbors an integrin a1b1 recognition site in its C-Terminal domains. J Biol Chem 281: 25745-25756, 2006
36. Eckes B, Zigrino P, Kessler D, Holtkö tter O, Shephard P, Mauch C, and Krieg T. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 19: 325-332, 2000
37. Emsley J, King SL, Bergelson JM, and Liddington RC. Crystal structure of the I domain from integrin a2b1. J Biol Chem 272: 28512-28517, 1997
38. Emsley J, Knight CG, Farndale RW, Barnes MJ, and C. LR. Structural basis of collagen recognition by integrin a2b1. Cell 100: 47-56, 2000
39. Erler JT, Bennewith KL, Nicolau M, Dornhö fer N, Kong C, Le Q-T, Chi J-TA, Jeffrey SS, and Giaccia AJ. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226, 2006
40. Fä hling M, Perlewitz A, Doller A, and Thiele B-J. Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia. Comp Biochem Physiol C Toxicol Pharmacol 139: 119-126, 2004
41. Falanga V, Martin TA, Takagi, H., Kirsner RS, Helfman T, Pardes J, and Ochoa MS. Low oxygen tension increases mRNA levels of a1(I) procollagen in human dermal fibroblasts J Cell Physiol 157: 408-412, 1993
42. Ffrench-Constant C. Alternative splicing of fibronectin - many different proteins but few different functions. Exp Cell Res 221: 261-271, 1995
43. Fiaschi T and Chiarugi P. Oxidative stress, tumor microenvironment, and metabolic reprogramming: A diabolic liaison. Int J Cell Biol 2012, 762825, 2012
44. Forman HJ, Maiorino M, and Ursini F. Signaling functions of reactive oxygen species. Biochemistry 49: 835-842, 2010
45. Gabbiani G. The myofibroblast in wound healing and fibrocontractive disease. J Pathol 200: 500-503, 2003
46. Gandhi NS and Mancera RL. The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72: 455-482, 2008
47. Gialeli C, Theocharis AD, and Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278: 16-27, 2011
48. Giannoni E and Chiarugi P. Redox circuitries driving Src regulation. Antioxid Redox Signal 20: 2011-2025, 2014
49. Gilkes DM, Saumendra B, Chaturvedi P, Wirtz D, and Semenza GL. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodelling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J Biol Chem 288: 10819-10829, 2013
50. Go Y-M and Jones DP. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation 111: 2973-2980, 2005
51. Gordon MK and Hahn RA. Collagens. Cell Tissue Res 339: 427-457, 2009
52. Grassian AR, Coloff JL, and Brugge JS. Extracellular matrix regulation of metabolism and implications for tumorigenesis. Cold Spring Harb Symp Quant Biol 76: 313-324, 2011
53. Grassian AR, Metallo CM, Coloff JL, Stephanopoulos G, and Brugge JS. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev 25: 1716-1733, 2011
54. Grote F, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, and Schieffer B. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-related reactive oxygen species. Circ Res 92: E80-e86, 2003
55. Guadall A, Orriols M, Rodríguez-Calvo R, Calvayrac O, Crespo J, Aledo R, Martínez-González J, and Rodríguez C. Fibulin-5 is up-regulated by hypoxia in endothelial cells through a hypoxia-inducible factor-1 (HIF-1a)-dependent mechanism. J Biol Chem 286: 7093-7103, 2011
56. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, and Winberg J-O. Regulation of matrix metalloproteinase activity in health and disease. FEBS J 278: 28-45, 2011
57. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, and Sorokin LM. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 85: 979-1000, 2005
58. Hanahan D and Weinberg RA. Hallmarks of cancer: The next generation. Cell 144: 646-674, 2011
59. Hecker L, Vittal R, Jones T, Jagirdir R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, and Thannickal VJ. NADPH-oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081, 2009
60. Heino J. The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 19: 319-323, 2000
61. Hessle H and Engvall E. Type VI collagen. Studies on its localization, structure, and biosynthetic form with monoclonal antibodies. J Biol Chem 259: 3955-3961, 1984
62. Higgins DF, Kimura K, Iwano M, and Haase VH. Hypoxiainducible factor signaling in the development of fibrosis. Cell Cycle 7: 1128-1132, 2008
63. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127: 526-537, 2007
64. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliére A, Varga J, De Wever O, Mareel M, and Gabbiani G. Recent developments in myofibroblast biology. Paradigms for connective tissue remodeling. Am J Pathol 180: 1340-1355, 2012
65. Hiraki M, Kitajima Y, Kai K, Nakamura J, Hashiguchi K, Noshiro H, and Miyazaki K. Knockdown of hypoxia-inducible factor-1a accelerates peritoneal dissemination via the upregulation of MMP-1 expression in gastric cancer cell lines. Exp Ther Med 4: 355-362, 2012
66. Horino Y, Takahashi S, Miura T, and Takahashi Y. Prolonged hypoxia accelerates the posttranscriptional process of collagen synthesis in cultured fibroblasts. Life Sci 71: 3031-3045, 2002
67. Humphries JD, Byron A, and Humphries MJ. Integrin ligands at a glance. J Cell Sci 119: 3901-3903, 2006
68. Hynes RO. A reevaluation of integrins as regulators of angiogenesis. Nat Med 8: 918-921, 2002
69. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002
70. Hynes RO. The extracellular matrix: Not just pretty fibrils. Science 326: 1216-1219, 2010
71. Hynes RO, George EL, Georges EN, Guan J-L, Rayburn H, and Yang JT. Toward a genetic analysis of cell-matrix adhesion. Cold Spring Harb Symp Quant Biol 17: 249-258, 1992
72. Iozzo R and Schaefer L. Proteoglycans in health and disease: Novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277: 3864-3875, 2010
73. Iozzo RV and Sanderson RD. Proteoglycans in cancer biology, tumor microenvironment and angiogenesis. J Cell Mol Med 15: 1013-1031, 2011
74. Iyer PR, Patterson NL, Fields GB, and Lindsey ML. The history of matrix metalloproteinases: Milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol 303: H919-H930, 2012
75. Jing S-W, Wang Y-D, Kuroda M, Su J-W, Sun G-G, Liu Q, Cheng Y-J, and Yang C-R. HIF-1a contributes to hypoxiainduced invasion and metastasis of esophageal carcinoma via inhibiting E-cadherin and promoting MMP-2 expression. Acta Med Okayama 65: 399-407, 2012
76. Kaelin WGJ and Ratcliffe PJ. Oxygen sensing by metazoans: The central role of HIF hydroxylase pathway. Mol Cell 30: 393-402, 2008
77. Kamata T, Ambo H, Puzon-McLaughlin W, Tieu KK, Handa M, Ikeda Y, and Takada Y. Critical cysteine residues for regulation of integrin aIIbb3 are clustered in the epidermal growth factor domains of the b3 subunit. Biochem J 378: 1079-1082, 2004
78. Kamata T, Handa M, Ito S, Sato Y, Ohtani T, Kawai Y, and Ikeda Y. Structural requirements for activation in aIIbb3 integrin. J Biol Chem 285: 38428-38437, 2010
79. Kamata T, Handa M, Sato Y, Ikeda Y, and Aiso S. Membrane-proximal a/b stalk interactions differentially regulate integrin activation. J Biol Chem 280: 24775-24783, 2004
80. Kanchanawong P, Shtengel G, Pasapera AM, Rambko EB, Davidson MW, Hess HF, and Waterman CM. Nanoscale architecture of integrin-based cell adhesions. Nature 468: 580-584, 2010
81. Kar S, Subbaram S, Carrico PM, and Melendez JA. Redoxcontrol of matrix metaloproteinase-1: A critical link between free radicals, matrix remodeling and degenerative disease. Respir Physiol Neurobiol 174: 299-306, 2010
82. Khoshnoodi J, Pedchenko V, and Hudson BG. Mammalian collagen IV. Microsc Res Tech 71: 357-370, 2008
83. Klingberg F, Hinz B, and White ES. The myofibroblast matrix: Implications for tissue repair and fibrosis. J Pathol 229: 298-309, 2013
84. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, and Barnes MJ. The collagen-binding A-domains of integrins a1b1 and a2b1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 275: 35-40, 2000
85. Koch S, Volkmar CM, Kolb-Bachofen V, Korth HG, Kirsch M, Horn AH, Sticht H, Pallua N, and Suschek CV. A new redox-dependent mechanism of MMP-1 activity control comprising reduced low-molecular-weight thiols and oxidizing radicals. J Mol Med 87: 261-272, 2009
86. Krokhin OV, Cheng K, Sousa SL, Ens W, Standing KG, and Wilkins JA. Mass spectrometric based mapping of disulfide bonding patterns of integrin a chains. Biochemistry 42: 12950-12959, 2003
87. Kü hn K. Basement membrane (type IV) collagen. Matrix Biol 14: 439-445, 1995
88. Lahav J, Gofer-Dadosh N, Luboshitz J, Hess O, and Shaklai M. Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett 475: 89-92, 2000
89. Lahav J, Jurk K, Hess O, Barnes MJ, Farndale RW, Luboshitz J, and Kehrel BE. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 100: 2472-2478, 2002
90. Lampe AK and Bushby KMD. Collagen VI related muscle disorders. J Med Genet 42: 673-685, 2005
91. Laragione T, Bonetto V, Casoni F, Massignan T, Bianchi G, Gianazza E, and Ghezzi P. Redox regulation of surface protein thiols: Identification of integrin a-4 as a molecular target by using redox proteomics. Proc Natl Acad Sci USA 100: 14737-14741, 2003
92. Leahy DJ, Aukhil I, and Erickson HP. 2.0A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 84: 155-164, 1996
93. Ley K, Laudanna C, Cybulsky MI, and Noushargh S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689, 2007
94. Lijnen PJ, van Pelt JF, and Fagard RH. Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts. Cardiovasc Ther 30: E1-e8, 2010
95. Lin L-J, Grimme JM, Sun J, Lu S, Gai L, Cropek DM, and Wang Y. The antagonistic roles of PDGF and integrin avb3 in regulating ROS production at focal adhesions. Biomaterials 34: 3807-3815, 2013
96. Luo B-H, Springer TA, and Takagi J. A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol 2: 0776-0786, 2004
97. Mä ki JM. Lysyl oxidase: An oxidative enzyme and effector of cell function. Cell Mol Life Sci 63: 2304-2316, 2009
98. Manickam N, Ahmad SS, and Essex DW. Vicinal thiols are required for activation of the aIIbb3 platelet integrin. J Thromb Haemost 9: 1207-1215, 2011
99. Mas-Moruno C, Rechenmacher F, and Kessler H. Cilengitide: The first anti-Angiogenic small molecule drug candidate, design, synthesis and clinical evaluation. Anticancer Agents Med Chem 10: 753-768, 2010
100. Massagué J. TGFb signalling in context. Nat Rev Mol Cell Biol 13: 616-630, 2012
101. Massagué J, Seoane J, and Wotton D. Smad transcription factors. Genes Dev 19: 2783-2810, 2005
102. Matheny HE, Deem TL, and Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol 164: 6550-6559, 2000
103. Meng D, Dan-Dan L, and Fang J. Insulin-like growth factor-1 induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovasc Res 80: 299-308, 2008
104. Metcalf DG, Moore DT, Wu Y, Kielec JM, Molnar K, Valentine KG, Wand AJ, Bennett JS, and DeGrado WF. NMR analysis of the aIIbb3 cytoplasmic interaction suggests a mechanism for integrin activation. Proc Natl Acad Sci USA 107: 22481-22486, 2010
105. Metcalfe C, Cresswell P, Ciaccia L, Thomas B, and Barclay AN. Labile disulfide bonds are common at the leukocyte cell surface. Open Biol 1: 110010, 2011
106. Milet-Marsal S, Breillat C, Peyruchaud O, Nurden P, Combrie ́ R, Nurden A, and Bourre F. Two different b3 cysteine substitutions alter aIIbb3 maturation and result in Glanzmann thrombasthenia. Thromb Haemost 88: 104-110, 2002
107. Miner JH. The glomerular basement membrane. Exp Cell Res 318: 973-978, 2012
108. Mishina NM, Tyurin-Kuzmin PA, Markvicheva KN, Vorotnikov AV, Tkachuk V, Laketa V, Schultz C, Lukyanov S, and Belousov VV. Does cellular hydrogen peroxide diffuse or act locally?. Antioxid Redox Signal 14: 1-7, 2011
109. Mor-Cohen R, Rosenberg N, Einav Y, Zelzion E, Landau M, Averbukh Y, and Seligsohn U. Unique disulfide bonds in epidermal growth factor (EGF) domains of b3 affect structure and function of aIIbb3 and avb3 integrins in different manner. J Biol Chem 287: 8879-8891, 2012
110. Mor-Cohen R, Rosenberg N, Landau M, Lahav J, and Seligsohn U. Specific cysteines in b3 are involved in disulfide bond exchange-dependent and - independent activation of aIIbb3. J Biol Chem 283: 19235-19244, 2008
111. Moreth K, Iozzo RV, and Schaefer L. Small leucine-rich proteoglycans orchestrate crosstalk during inflammation. Cell Cycle 11: 2084-2091, 2012
112. Mott J and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16: 558-564, 2004
113. Mou Y, Ni H, and Wilkins JA. The selective inhibition of b1 and b7 integrin-mediated lymphocyte adhesion by bacitracin. J Immunol 161: 6323-6329, 1998
114. Murphy DD, Reddy EC, Moran N and O'Neill S. Regulation of platelet activity in a changing redox environment. Antioxid Redox Signal 20: 2074-2089, 2014
115. Myllyharju J. Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their role as treatment targets. Ann Med 40: 402-417, 2008
116. Myllyharju J and Koivunen P. Hypoxia-inducible factor prolyl 4-hydroxylases: Common and specific roles. Biol Chem 394: 435-448, 2013
117. Myllyharju J and Schipani E. Extracellular matrix genes as hypoxia-inducible targets. Cell Tissue Res 339: 19-29, 2009
118. Nagae M, Re S, Mihara E, Nogi T, Sugita Y, and Takagi J. Crystal structure of a5b1 integrin ectodomain: Atomic details of the fibronectin receptor. J Cell Biol 197: 131-140, 2012
119. Nagata M. Inflammatory cells and oxygen radicals. Curr Drug Targets Inflamm Allergy 4: 503-504, 2005
120. Nakamuta M, Higashi N, Kohijama M, Fukushima M, Ohta S, Kotoh K, Kobayashi N, and Enjoji M. Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells. Int J Mol Med 16: 677-681, 2005
121. Navdaev A, Heitmann V, deSantana Evangelista K, Mö rgelin M, Wegener J, and Eble JA. The C-Terminus of the c2 chain but not of the b3 chain of laminin-332 is indirectly but indispensably necessary for integrin-mediated cell reactions. Exp Cell Res 314: 489-497, 2008
122. Nelson KK, Ranganathan AC, Mansouri J, Rodriguez AM, Providence KM, Rutter JL, Pumiglia K, Bennett JA, and Melendez JA. Elevated SOD2 activity augments matrix metalloproteinase expression: Evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 9: 424-432, 2003
123. Nelson KK, Subbaram S, Connor KM, Dasgupta J, Ha XF, Meng TC, Tonks NK, and Melendez JA. Redox-dependent matrix-metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs. J Biol Chem 281: 14100-14110, 2006
124. Norman JT, Clark IM, and Garcia PL. Regulation of TIMP-1 expression by hypoxia in kidney fibroblasts. Ann N Y Acad Sci 878: 503-505, 1999
125. Orbe J, Rodriguez JA, Arias R, Belzunce M, Nespereira B, Perez-Ilzarbe M, Roncal C, and Paramo JA. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: Implication for plaque stabilization. Atherosclerosis 167: 45-53, 2003
126. Otranto M, Sarrazy V, Bonté F, Hinz B, Gabbiani G, and Desmoulière A. The role of the myofibroblast in tumor stroma remodelling. Cell Adh Migr 6: 203-2012, 2012
127. Petry A,WeitnauerM, and Gö rlach A. Receptor activation of NADPH oxidases. Antioxid Redox Signal 13: 467-487, 2010
128. Poole LB and Nelson KJ. Discovering mechanisms of signaling-mediated cysteine oxidation. Curr Opin Chem Biol 12: 18-24, 2008
129. Prince JM, Klinowska TCM, Marshman E, Lowe ET, Mayer U, Miner J, Aberdam D, Vestweber D, Gusterson B, and Streuli CH. Cell-matrix interactions during development and apoptosis of the mouse mammary gland in vivo. Dev Dyn 223: 497-516, 2002
130. Pytela R, Pierschbacher MD, Argraves S, Suzuki S, and Ruoslahti E. Arginine-glycine-Aspartic acid adhesion receptors. Methods Enzymol 144: 475-489, 1987
131. Qu A and Leahy DJ. Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, aLb2) integrin. Proc Natl Acad Sci USA 92: 10277-10281, 1995
132. Rajagopalan S, Meng P, Ramasamy S, Harrison DG, and Galis ZS. Reactive oxygen species produced by macrophagederived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98: 2572-2579, 1996
133. Randi AM and Hogg N. I domain of b2 integrin lymphocyte function-Associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1. J Biol Chem 269: 12395-12398, 1994
134. Ricard-Blum S. The collagen family. Cold Spring Harb Perspect Biol 3: 1-19, 2011
135. Robinson A, O'Neill S, Kiernan A, O'Donoghue N, and Moran N. Bacitracin reveals a role for multiple thiol isomerases in platelet function. Br J Haematol 132: 339-349, 2005
136. Romagnoli C, Marcucci T, Picariello L, Tonelli F, Vincenzini MT, and Iantomasi T. Role of N-Acetylcysteine and GSH redox system on total and active MMP-2 in intestinal myofibroblasts of Crohn's disease patients. Int J Colorectal Dis 28, 915-924, 2013
137. Rowe RG and Weiss SJ. Breaching the basement membrane: Who, when and how?. Trends Cell Biol 18: 560-574, 2008
138. Rucker RB and Murray J. Cross-linking amino acids in collagen and elastin. Am J Clin Nutr 31: 1221-1236, 1978
139. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697-715, 1996
140. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Puigserver P, and Brugge JS. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461: 109-113, 2009
141. Schröder K. NADPH oxidases in redox regulation of cell adhesion and migration. Antioxid Redox Signal 20: 2043-2058, 2014
142. Schröder E and Eaton P. Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: Issues and considerations. Curr Opin Pharmacol 8: 153-159, 2008
143. Serini G, Bochaton-Piallat, Ropraz P, Geinoz A, Borsi L, Zardi L, and Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-b1. J Cell Biol 142: 873-881, 1998
144. Shattil SJ, Kim C, and Ginsberg MH. The final steps in integrin activation: The end game. Nat Rev Mol Cell Biol 11: 288-300, 2010
145. Sheik FG, Pahan K, KhanM, Barbosa E, and Singh I. Abnormality in catalse import into peroxisomes leads to severe neurological disorder. Proc Natl Acad Sci USA 95: 2961-2966, 1998
146. Sherratt MJ. Tissue elasticity and the ageing elastic fibre. Age 31: 305-325, 2009
147. Shi M-J, Sundramurthy K, Liu B, Tan S-M, Law SKA, and Lescar J. The crystal structure of the plexin-semaphorinintegrin domain/hybrid domain/I-EGF1 segment from the human integrin b2 subunit at 1.8-A resolution. J Biol Chem 280: 30586-30593, 2005
148. Shimaoka M and Springer TA. Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov 2: 703-717, 2003
149. Shimaoka M, Takagi J, and Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biol Struct 31: 485-516, 2002
150. Shimaoka M, Xiao T, Liu J-H, Yang Y, Dong Y, Jun C-D, McCormackA,ZhangR, Joachimiak A, andTakagi J. Structures of the aLIdomainandits complexwithICAM-1reveal a shapeshifting pathway for integrin regulation. Cell 112: 99-111, 2003
151. Singh P, Carraher C, and Schwarzbauer JE. Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26: 397-419, 2010
152. Sudgen MC and Holness MJ. Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem 112: 139-149, 2006
153. Sun Q-H, Liu C-Y, Wang R, Paddock C, and Newman PJ. Disruption of the long-range GPIIIa Cys5-Cys435 disulfide bond results in the production of constitutively active GPIIb-GPIIIa (aIIbb3) integrin complexes. Blood 100: 2094-2101, 2002
154. Swiatkowska M, Szymanski J, Padula G, and Cierniewski C. Interaction and functional association of protein disulfide isomerase with avb3 integrin on endothelial cells. FEBS J 275: 1813-1823, 2008
155. Taddei ML, Parri M, Mello T, Catalano A, Levine AD, Raugei G, Ramponi G, and Chiarugi P. Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. Antioxid Redox Signal 9: 469-481, 2007
156. Takagi J and Springer TA. Integrin activation and structural rearrangement. Immunol Rev 186: 141-163, 2002
157. Takagi J, Beglova N, Yalamanchili P, Blacklow SC, and Springer TA. Definition of the EGF-like, closely interacting modules that bear activation epitopes in integrin b subunits. Proc Natl Acad Sci USA 98: 11175-11180, 2001
158. Takahashi Y, Takahashi S, Shiga Y, Yoshimi T, and Miura T. Hypoxic induction of prolyl 4-hydroxylase a(I) in cultured cells. J Biol Chem 275: 14139-14146, 2000
159. Timpl R, Sasaki T, Kostka G, and Chu M-L. Fibulins: A versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4: 479-489, 2003
160. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, and Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363, 2002
161. Tomasek JJ, Vaughan MB, Kropp BP, Gabbiani G, Martin MD, Haaksma CJ, and Hinz B. Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity. Wound Repair Regen 14: 313-320, 2006
162. Vanacore R, Ham A-JL, Voehler M, Sanders CR, Conrads TP, Veenstra TD, Sharpless KB, Dawson PE, and Hudson BG. A sulfilimine bond identified in collagen IV. Science 325: 1230-1234, 2009
163. Van Obberghen-Schilling E, Tucker RT, Saupe F, Gasser I, Cseh B, and Orend G. Fibronectin and tenascin-C: Accomplices in vascular morphogenesis during development and tumor growth. Int J Dev Biol 55: 511-525, 2011
164. Verhaar R, Dekkers DWC, DeCuyper IM, Ginsberg MH, de Korte D, and Verhoeven AJ. UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin aIIbb3. Blood 112: 4935-4939, 2008
165. Vestweber D. Novel insights into leukocyte extravasation. Curr Opin Hematol 19: 212-217, 2012
166. von der Mark H, Aumailley M, Wick G, Fleischmajer R, and Timpl R. Immunochemistry, genuine size and longspacing fibrils: Relation to type VI collagen. Eur J Biochem 142: 493-502, 1984
167. Wanders RJ. Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab 83: 16-27, 2004
168. Wang JH, Fu G, and Luo BH. Dissociation of the a-subunit calf-2 domain and the b-subunit I-EGF4 domain in integrin activation and signaling. Biochem 49: 10158-10165, 2010
169. Wang W and Luo B-H. Structural basis of integrin transmembrane activation. J Cell Biochem 109: 447-452, 2010
170. Wenk J, Brenneisen P, Wlaschek M, Poswig A, Briviba K, Oberley TD, and Scharffetter-Kochanek K. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 274: 25869-25876, 1999
171. White ES and Muro AF. Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models. IUBMB Life 63: 538-546, 2011
172. Wipff P-J, Rifkin DB, Meister J-J, and Hinz B. Myofibroblast contraction activates latent TGF-b1 from the extracellular matrix. J Cell Biol 179: 1311-1323, 2007
173. Wiradjaja F, DiTommaso T, and Smyth I. Basement membranes in development and disease. Birth Defects Res C Embryo Today 90: 8-31, 2010
174. Worth DC and Parsons M. Advances in imaging cell-matrix adhesions. J Cell Sci 123: 3629-3638, 2010
175. Wouters MA, Rigoutsos I, Chu CK, Feng LL, Sparrow DB, and Dunwoodie SL. Evolution of distinct EGF domains with specific functions. Protein Sci 14: 1091-1103, 2005
176. Xiao T, Takagi J, Coller BS, Wang JH, and Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432: 59-67, 2004
177. Xie C, Zhu J, Chen X, Mi L, Nishida N, and Springer TA. Structure of an integrin with an aI domain, complement receptor type 4. EMBO J 29: 666-679, 2010
178. Xiong J-P, Mahalingam B, Alonso JL, Borelli LA, Rui X, Anand S, Hyman BT, Rysiok T, Mü ller-Pompalla D, Goodman SL, and Arnaout MA. Crystal structure of the complete integrin aVb3 ectodomain plus an a/b transmembrane fragment. J Cell Biol 186: 589-600, 2009
179. Xiong J-P, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL, Joachimiak A, Goodman SL, and Arnaout MA. Crystal structure of the extracellular segment of integrin aVb3. Science 294: 339-345, 2001
180. Xiong J-P, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman S, and Arnaout MA. Crystal structure of the extracellular segment of integrin aVb3 in complex with Arg-Gly-Asp ligand. Science 296: 151-155, 2002
181. Yan B and Smith JW. Mechanism of integrin activation by disulfide bond reduction. Biochem 40: 8861-8867, 2001
182. Yan B, Hu DD, Knowles SK, and Smith JW. Probing chemical and conformational differences in the resting and active conformers of platelet aIIbb3. J Biol Chem 275: 7249-7290, 1999
183. Yang W, Shimaoka M, Salas A, Takagi J, and Springer TA. Intersubunit signal transmission in integrins by a receptorlike interaction with a pull spring. Proc Natl Acad Sci USA 101: 2906-2911, 2003
184. Yurchenco P and Patton BL. Developmental and pathogenic mechanisms of basement membrane assembly. Curr Pharm Des 15: 1277-1294, 2009
185. Zang Q and Springer TA. Amino acid residues in the PSI domain and cysteine-rich repeats of the integrin b2 subunit that restrain activation of the integrin axb2. J Biol Chem 276: 6922-6929, 2001
186. Zaw KK, Yokoyama Y, Abe M, and Ishikawa O. Catalase restores the altered mRNA expression of collagen and matrix metalloproteinases by dermal fibroblasts exposed to reactive oxygen species. Eur J Dermatol 16: 375-379, 2006
187. Zhang W-M, Käpylä J, Puranen JS, Knight CG, Tiger C-F, Pentikäinen OT, Johnson MS, Farndale RW, Heino J, and Gullberg D. a11b1 integrin recognizes the GFOGER sequence in interstitial collagens. J Biol Chem 279: 7270-7277, 2003
188. Zhao T, Benard V, Bohl BP, and Bokoch GM. The molecular basis for adhesion-mediated suppression of reactive oxygen species generation by human neutrophils. J Clin Invest 112: 1732-1740, 2003
189. Zhu J, Carman CV, Kim M, Shimaoka M, Springer TA, and Luo B-H. Requirement of a and b subunit transmembrane helix separation for integrin outside-in signaling Blood 110: 2475-2483, 2007.